Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Nanoviricides Inc (NNVC)

Nanoviricides Inc (NNVC)
1.0500 x 1 1.4400 x 1
Pre-market by (Cboe BZX)
1.2700 -0.0100 (-0.78%) 03/26/25 [NYSE Arca]
1.0500 x 1 1.4400 x 1
Pre-market 1.2700 unch (unch) 20:00 ET
Quote Overview for Wed, Mar 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.2550
Day High
1.3208
Open 1.3100
Previous Close 1.2800 1.2800
Volume 47,000 47,000
Avg Vol 168,430 168,430
Stochastic %K 68.06% 68.06%
Weighted Alpha -19.93 -19.93
5-Day Change -0.0200 (-1.55%) -0.0200 (-1.55%)
52-Week Range 1.0297 - 3.5900 1.0297 - 3.5900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,020
  • Shares Outstanding, K 15,641
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,290 K
  • EBIT $ -10 M
  • EBITDA $ -9 M
  • 60-Month Beta 1.14
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.79

Options Overview Details

View History
  • Implied Volatility 368.43% ( +34.55%)
  • Historical Volatility 84.74%
  • IV Percentile 83%
  • IV Rank 44.55%
  • IV High 776.24% on 02/11/25
  • IV Low 40.76% on 09/16/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 85
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 1,908
  • Open Int (30-Day) 2,453

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.60
  • Growth Rate Est. (year over year) +166,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1100 +14.41%
on 03/04/25
Period Open: 1.3100
1.3700 -7.30%
on 03/20/25
-0.0400 (-3.05%)
since 02/26/25
3-Month
1.0311 +23.17%
on 01/28/25
Period Open: 1.5100
1.6500 -23.03%
on 01/06/25
-0.2400 (-15.89%)
since 12/26/24
52-Week
1.0297 +23.34%
on 04/25/24
Period Open: 1.1400
3.5900 -64.62%
on 06/10/24
+0.1300 (+11.40%)
since 03/26/24

Most Recent Stories

More News
NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company

SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company")(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the...

NNVC : 1.2700 (-0.78%)
NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company

SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company")(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the...

NNVC : 1.2700 (-0.78%)
Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan

SHELTON, CT / ACCESS Newswire / March 4, 2025 / The HHS Department Secretary Robert F. Kennedy Jr. wrote an Opinion piece in the FoxNews entitled "Measles outbreak is call to action for all of us". He...

NNVC : 1.2700 (-0.78%)
Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan

SHELTON, CT / ACCESS Newswire / March 4, 2025 / The HHS Department Secretary Robert F. Kennedy Jr. wrote an Opinion piece in the FoxNews entitled "Measles outbreak is call to action for all of us". He...

NNVC : 1.2700 (-0.78%)
NanoViricides, Inc. Has Filed its Quarterly Report

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu

NNVC : 1.2700 (-0.78%)
NanoViricides, Inc. Has Filed its Quarterly Report

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu

NNVC : 1.2700 (-0.78%)
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum...

NNVC : 1.2700 (-0.78%)
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum...

NNVC : 1.2700 (-0.78%)
NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025

SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus...

NNVC : 1.2700 (-0.78%)
NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025

SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus...

NNVC : 1.2700 (-0.78%)

Business Summary

NanoViricides, Inc. is a development stage company focused on creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. It also focuses on the development...

See More

Key Turning Points

3rd Resistance Point 1.3747
2nd Resistance Point 1.3477
1st Resistance Point 1.3089
Last Price 1.2700
1st Support Level 1.2431
2nd Support Level 1.2161
3rd Support Level 1.1773

See More

52-Week High 3.5900
Fibonacci 61.8% 2.6120
Fibonacci 50% 2.3098
Fibonacci 38.2% 2.0077
Last Price 1.2700
52-Week Low 1.0297

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies